Related references
Note: Only part of the references are listed.Expert Perspective: An Approach to Refractory Lupus Nephritis
Swati Arora et al.
ARTHRITIS & RHEUMATOLOGY (2022)
Leflunomide: A safe and effective alternative in systemic lupus erythematosus
L. Polinoa et al.
AUTOIMMUNITY REVIEWS (2022)
Leflunomide versus azathioprine for maintenance therapy of lupus nephritis: a prospective, multicentre, randomised trial and long-term follow-up
Qiong Fu et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Long-term outcome and predictors of long-term outcome in patients with lupus nephritis managed at a tertiary hospital in Mumbai
Sandeep Yadav et al.
LUPUS (2022)
KDIGO 2021 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF GLOMERULAR DISEASES
Brad H. Rovin et al.
KIDNEY INTERNATIONAL (2021)
Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis
Xia Zhang et al.
RHEUMATOLOGY AND THERAPY (2021)
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
Dimitrios Mougiakakos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Treating rheumatoid arthritis with leflunomide monotherapy versus combination therapy with methotrexate
Daniel Ampessan Guadagnin et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY (2021)
Efficacy and safety of bortezomib in refractory lupus nephritis: a single-center experience
A. Segarra et al.
LUPUS (2020)
Update on Lupus Nephritis: Core Curriculum 2020
Samir Parikh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus
Lennard Ostendorf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effectiveness and safety of methotrexate versus leflunomide in 12-month treatment for Takayasu arteritis
Chunling Wu et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2020)
Cyclophosphamide Versus Mycophenolate Versus Rituximab in Lupus Nephritis Remission Induction A Historical Head-to-Head Comparative Study
Rudra Prosad Goswami et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2019)
Refractory lupus nephritis: When, why and how to treat
Andreas Kronbichler et al.
AUTOIMMUNITY REVIEWS (2019)
Pulmonary arterial hypertension associated with protein kinase inhibitors: a pharmacovigilance-pharmacodynamic study
Lucie Cornet et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Treatment Options for Refractory Lupus Nephritis
Hans-Joachim Anders et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus Nephritis
Xianghua Huang et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Assessing the relative impact of lupus nephritis on mortality in a population-based systemic lupus erythematosus cohort
S. E. Reppe Moe et al.
LUPUS (2019)
Impact of stringent response in proteinuria on long-term renal outcomes in proliferative lupus nephritis
J. Won et al.
LUPUS (2019)
Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: a randomized trial
Minfang Zhang et al.
CLINICAL RHEUMATOLOGY (2019)
Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices
Ingeborg M. Bajema et al.
KIDNEY INTERNATIONAL (2018)
Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis
C-B Choi et al.
LUPUS (2018)
Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus
S. Iwata et al.
LUPUS (2018)
Update on Lupus Nephritis
Salem Almaani et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Analysis of the effectiveness and safety of rituximab in patients with refractory lupus nephritis: a chart review
Anne Contis et al.
CLINICAL RHEUMATOLOGY (2016)
A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis
Hans-Joachim Anders et al.
KIDNEY INTERNATIONAL (2016)
The Efficacy and Safety of Leflunomide for the Treatment of Lupus Nephritis in Chinese Patients: Systematic Review and Meta-Analysis
Heng Cao et al.
PLOS ONE (2015)
Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis
R. J. Davies et al.
LUPUS (2013)
Long-term follow-up in lupus nephritis patients treated with rituximab-clinical and histopathological response
Thorunn Jonsdottir et al.
RHEUMATOLOGY (2013)
Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2012)
Therapeutic effect of leflunomide on the development of experimental lupus nephritis in mice
Chunyan He et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Long-term outcomes-mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases
Josefina Cortes-Hernandez et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Gerald B. Appel et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis
Iva Gunnarsson et al.
ARTHRITIS AND RHEUMATISM (2007)
Share Paper
